extensive stage small cell lung cancer

Known as: lung cancer, extensive stage small cell, Small Cell Lung Cancer, Extensive Stage, Extensive Stage Small Cell Lung Carcinoma 
Small cell lung carcinoma which has spread beyond one hemi-thorax and the regional lymph nodes.
National Institutes of Health

Topic mentions per year

Topic mentions per year

1980-2017
0102019802017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2013
Highly Cited
2013
Myeloid-derived suppressor cells (MDSC) are one of the major factors limiting the efficacy of immune therapy. In a clinical trial… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2012
2012
BACKGROUND AND PURPOSE To define the rate of development of symptomatic chest failures in extensive stage small cell lung cancer… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
Is this relevant?
2011
2011
PURPOSE We conducted a phase II study of combination chemotherapy with irinotecan (CPT-11) and nedaplatin (NDP), (INP regimen… (More)
  • table 1
  • table 2
  • figure 1
Is this relevant?
2011
2011
BACKGROUND AT-101 is an oral inhibitor of the antiapoptotic Bcl proteins (Bcl-2, Bcl-XL, Bcl-W, and Mcl-1) and an inducer of the… (More)
Is this relevant?
2011
2011
BACKGROUND The authors conducted a retrospective study to evaluate the effects of thoracic radiation therapy (TRT) for patients… (More)
Is this relevant?
2009
2009
We performed a phase II trial to test whether a cyclooxygenase (COX-2) inhibitor, celecoxib, added to standard first-line… (More)
Is this relevant?
Highly Cited
2006
Highly Cited
2006
PURPOSE The initial goal of this study was to test the immunologic and clinical effects of a new cancer vaccine consisting of… (More)
  • figure 1
  • table 2
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2006
2006
BACKGROUND In preclinical models, the proteasome inhibitor bortezomib (PS-341) inhibits the growth of small cell lung cancer… (More)
Is this relevant?
1999
1999
PURPOSE This phase II multi-institutional trial of the Southwest Oncology Group was designed to evaluate the efficacy and… (More)
Is this relevant?
1990
1990
We devised a novel clinical protocol for extensive-stage small cell lung cancer (SCLC), selecting chemotherapy whenever possible… (More)
Is this relevant?